Kwan Pui San

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(15%)(5%)(36%)(39%)0%
Sale Success Rate4 of 52 of 50 of 50 of 50 of 5

ChemoCentryx, Inc.

Drugs » Biotechnology

Principal Acctg Officer:

Holdings: 3.23K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--